FDA grants RMAT to Poseida’s CAR-T cell therapy P-BCMA-ALLO1
Poseida Therapeutics has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for…
Poseida Therapeutics has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for…
MaxCyte, a company specialising in cell engineering technologies, has entered a strategic platform licence (SPL) agreement with Kamau Therapeutics, a…
China’s National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) has granted breakthrough therapy designation (BTD) for GSK's Blenrep…
Roche has secured approval from the US Food and Drug Administration (FDA) for Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) with biopharmaceutical…
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotechnology for FS001, a potentially first-in-class antibody-drug conjugate (ADC). This…
Bayer and Asklepios BioPharmaceutical (AskBio) have announced US Food and Drug Administration (FDA) fast track designation for AB-1005, a gene…
Pan Cancer T, a US biotech firm specialising in next-generation T cell therapies for solid tumours, has announced the successful…
Tiba Biotech, a US preclinical biopharmaceutical company based in Cambridge, Massachusetts, has announced a partnership with the Biomedical Advanced Research…
Clinical-stage biopharmaceutical companies NextCure and LegoChem Biosciences have signed a collaboration and co-development agreement to develop a B7-H4 antibody drug…
Concept: Israel startup Inspekto has unveiled the second generation of its autonomous machine vision (AMV) system ‘INSPEKTO S70 Gen.2’ for…